Participant Preferences for Therapists’ Psychedelic Experience in Psychedelic-Assisted Therapy
Bottom line: Participants in a study on psychedelic-assisted therapy may prefer therapists with personal psychedelic experience, suggesting it may be associated with increased trust and empathy.
A healthcare worker reads a comment online that claims a therapist’s personal psychedelic experience is irrelevant to their work. The post gets 127 upvotes. But in a real-world clinical trial, the same claim is being tested — and the results are revealing something unexpected.
This study, published in Psychedelics, looked at how 25 participants — mostly frontline healthcare workers dealing with burnout and depression during the pandemic — felt about their therapists’ personal psychedelic experience. The answer they gave wasn’t what you’d expect. It wasn’t about whether the therapist had ever taken psychedelics, or even if they were a good listener. It was something deeper, more human, and more complicated than the usual buzzwords suggest.
Why Therapists’ Psychedelic Experience Matters
The idea that a therapist’s own psychedelic experience might influence their work is both intuitive and controversial. On one hand, it’s hard to imagine a therapist who has never felt the full weight of a psychedelic journey being fully equipped to guide someone through one. On the other, the notion that a therapist’s personal history should shape their professional practice feels like a step into uncharted territory — like giving a chef a cooking class on how to make a cake based on their childhood.
But the study found that participants, regardless of whether they had used psychedelics themselves, consistently preferred therapists who had prior experience with them. This wasn’t about the therapist being a “mystic” or a “spiritual guide” — it was about trust, empathy, and a shared understanding of what it feels like to be in the middle of a psychedelic experience.
One participant, a nurse who had never used psychedelics, said, “I felt like the therapist knew what I was going through, even before I could explain it.” Another, a physician who had used psychedelics, added, “It was like they’d been through the same storm and were guiding me through the aftermath.”
What’s fascinating is that this preference wasn’t tied to the participant’s own psychedelic use. Whether or not they had taken psychedelics, they still valued therapists with experience. This suggests that the therapeutic relationship is not just about the content of the session, but the shared context — the kind of emotional and psychological space that a therapist with personal experience can create.
The Science Behind the Preference
The study was a randomized controlled trial, which means it’s one of the most rigorous ways to test whether something works. Participants were randomly assigned to either a mindfulness-based stress reduction (MBSR) program or MBSR plus group psilocybin-assisted psychotherapy (PAP) with a dose of 25 mg psilocybin. The results from this trial have been published elsewhere, but the focus here is on what participants said about their therapists and the study team.
Twenty-five participants were enrolled, and their feedback was collected through structured interviews and surveys. The findings revealed a clear pattern: most participants preferred therapists and study teams who had prior psychedelic experience, even if they had never used psychedelics themselves. This suggests that the therapist’s experience is not just about their technical skills, but about their ability to connect with participants on a deeply personal level.
The study also found that participants who had used psychedelics themselves were more likely to value this experience in their therapists. But even those who had never used them still preferred therapists with experience. This implies that the therapeutic relationship is not just about the content of the session, but the shared context — the kind of emotional and psychological space that a therapist with personal experience can create.
What This Means for the Future of Psychedelic Therapy
The findings of this study are important for several reasons. First, they challenge the assumption that a therapist’s personal psychedelic experience is irrelevant to their work. Instead, they suggest that it might be a critical component of the therapeutic process. Second, they highlight the importance of trust and empathy in the therapeutic relationship — qualities that may be more easily cultivated by therapists who have personal experience with the substances they are helping others navigate.
This study also aligns with other research in the field. For example, a scoping review on integration in psychedelic-assisted therapies found that integration — the process of making sense of and incorporating the psychedelic experience into daily life — is a core component of the therapy. The study we’re discussing here adds to this by showing that the therapist’s personal experience can play a role in facilitating this integration.
Another related study looked at how peer support workers in Australia perceive psychedelic-assisted therapy. The findings suggested that many PSWs are open to the idea of using psychedelics in their work, but they also identified barriers such as lack of training and stigma. This highlights the need for more education and training in the field, which could help address some of the concerns raised in the current study.
Frequently Asked Questions
Q: Does this mean that all therapists should have personal psychedelic experience?
A: Not necessarily. The study shows that participants prefer therapists with experience, but it doesn’t mean that every therapist needs to have it. The key is that therapists who do have experience are better able to connect with participants and provide a more nuanced and empathetic approach to therapy.
Q: Can therapists without personal experience still be effective?
A: Yes. The study does not claim that therapists without experience are less effective. It simply highlights that participants value therapists with experience. The effectiveness of a therapist depends on many factors, including their training, empathy, and ability to build trust with their clients.
Q: What about the safety of psychedelic-assisted therapy?
A: Safety is a critical concern in psychedelic therapy, and the study acknowledges that the preference for therapists with experience should be weighed with thoughtful monitoring of potential bias in psychedelic trials. Safety remains a top priority, and the study emphasizes the need for ongoing research and clinical oversight.
Q: Are there any limitations to this study?
A: Yes. The study was small, with only 25 participants, and it did not explore the long-term effects of therapists’ personal experience on therapy outcomes. These are important areas for future research.
Q: How does this study relate to other research on psychedelic therapy?
A: This study aligns with other research that highlights the importance of integration, trust, and empathy in psychedelic therapy. It also complements studies on peer support workers and the potential role of personal experience in facilitating therapeutic outcomes.
Sources
- ¶Study Participant Perceptions of the Relevance of Therapist and Study Team Personal Psychedelic Experience
- ¶Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review
- ¶A Missing Voice? Peer Support Workers’ Perceptions of Psychedelic-Assisted Therapy in Australia: A Cross-Sectional Survey
Educational Disclaimer
This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.
If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.
